Zurueck zur Suche

Reporte zur Charge FN6200

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 2 IN 1 LA 1 CA 1

VAERS 1255545

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FN6200

schwer
Staat
MI
Alter
-
Geschlecht
U
Eingang
15.05.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Bone pain Glossitis Haemorrhage Skin irritation Irritability Swelling face Swollen tongue Thrombosis

Symptomtext

I am bleeding heavily because I am getting blood clots and stuff like that; I am bleeding heavily because I am getting blood clots and stuff like that; Lot of pain in my joints and in my bones; Lot of pain in my joints and in my bones; Right side of face, my tongue inside is very swollen and irritated; Right side of face, my tongue inside is very swollen and irritated; Right side of face, my tongue inside is very swollen and irritated; Right side of face, my tongue inside is very swollen and irritated; This is a spontaneous report from two contactable consumers (one was the patient). A patient of unspecified age and gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FN6200), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation; axitinib (INLYTA), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) at 2 pills once a day for clear cell renal cancer; pembrolizumab (KEYTRUDA), route of administration, start and stop date, batch/lot number and dose were not reported for clear cell renal cancer; zoledronic acid (ZOMETA), route of administration, start and stop date, batch/lot number and dose were not reported for the bones. The patient received the first dose of BNT162B2 on unknown date (Lot Number: CL9265) for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was getting terrible side effects from either the axitinib or the pembrolizumab. The patient was bleeding very heavily and the right side of face and tongue inside was very swollen and irritated. The patient was getting a lot of pain in the joints and bones. The patient was bleeding heavily because was getting blood clots and "stuff like that" (as reported). The actions taken with axitinib, pzoledronic acid, and embolizumab were unknown." The outcome of the events was unknown. Follow up (23Apr2021): New information received from a contactable consumer includes reporter details. No Follow-up attempts are needed. No further information is expected. Follow-up (07May2021): This is a follow-up report to notify that the case 2021406450 and case 2021513212 are duplicates. All subsequent follow-up information will be reported under Manufacturer report number 2021513212.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1255545

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FN6200

schwer
Staat
MI
Alter
-
Geschlecht
U
Eingang
15.05.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Bone pain Glossitis Haemorrhage Skin irritation Irritability Swelling face Swollen tongue Thrombosis

Symptomtext

I am bleeding heavily because I am getting blood clots and stuff like that; I am bleeding heavily because I am getting blood clots and stuff like that; Lot of pain in my joints and in my bones; Lot of pain in my joints and in my bones; Right side of face, my tongue inside is very swollen and irritated; Right side of face, my tongue inside is very swollen and irritated; Right side of face, my tongue inside is very swollen and irritated; Right side of face, my tongue inside is very swollen and irritated; This is a spontaneous report from two contactable consumers (one was the patient). A patient of unspecified age and gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FN6200), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation; axitinib (INLYTA), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) at 2 pills once a day for clear cell renal cancer; pembrolizumab (KEYTRUDA), route of administration, start and stop date, batch/lot number and dose were not reported for clear cell renal cancer; zoledronic acid (ZOMETA), route of administration, start and stop date, batch/lot number and dose were not reported for the bones. The patient received the first dose of BNT162B2 on unknown date (Lot Number: CL9265) for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was getting terrible side effects from either the axitinib or the pembrolizumab. The patient was bleeding very heavily and the right side of face and tongue inside was very swollen and irritated. The patient was getting a lot of pain in the joints and bones. The patient was bleeding heavily because was getting blood clots and "stuff like that" (as reported). The actions taken with axitinib, pzoledronic acid, and embolizumab were unknown." The outcome of the events was unknown. Follow up (23Apr2021): New information received from a contactable consumer includes reporter details. No Follow-up attempts are needed. No further information is expected. Follow-up (07May2021): This is a follow-up report to notify that the case 2021406450 and case 2021513212 are duplicates. All subsequent follow-up information will be reported under Manufacturer report number 2021513212.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1823987

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FN6200

mild
Staat
IN
Alter
71,0
Geschlecht
F
Eingang
28.10.2021
Impfdatum
06.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Fatigue Headache Inappropriate schedule of product administration Myalgia

Symptomtext

Other Vaccine same date vaccine date: 06Mar2021; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; This is a spontaneous report from a contactable consumer. A 71-year-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN6199), dose 2 via an unspecified route of administration, administered in Arm Left on 06Mar2021 as dose 2, single for covid-19 immunisation (at the age of 71-year-old). Medical history included diabetes, hx breast cancer, arthritis from an unknown date and unknown if ongoing, Valium, rocephin, x-ray contrast ionic and non-ionic allergy from an unknown date and unknown if ongoing. Concomitant medications included metformin (MET-FORMIN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of bnt162b2 (Lot number FN6200) in Arm Left on 28Feb2021 09:30 AM as dose 1, single for covid-19 immunisation and experienced Severe joint and muscle pain, tiredness, daily head-ache. On an unspecified date of Mar2021 patient experienced severe joint and muscle pain, tiredness, daily headache about 1week after 1st injection and continued past 2nd injection up until 12Apr. The treatment was not received. Prior to vaccination, unknown if the patient diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was recovered. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Arthritis; Breast cancer; Contrast media allergy; Diabetes.
Andere Medikamente
METFORMIN.
Allergien
-
Vorherige Impfungen
-

VAERS 1628804

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FN6200

mild
Staat
LA
Alter
77,0
Geschlecht
F
Eingang
24.08.2021
Impfdatum
23.02.2021
Beginn
09.03.2021
Tage bis Beginn
14,0
Dosis
2
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cardiac flutter Chest discomfort Disorientation Fatigue Feeling abnormal Tension

Symptomtext

Episodes of feeling really bad, chest having extreme tension, heart flutters, tiredness, complete disorientation within these episodes. Slight disorientation event around 8/12/2021. No major events since. Feeling Better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
Saw family physician to no avail. Did nothing about it. Seemed like a joke to him. Never experienced anything like this before the vaccine.
Aktuelle Erkrankungen
UTI
Vorgeschichte
Diabetes, heart disease, one kidney
Andere Medikamente
Metoprolol, rosuvastatin, losartan, januvia, glimepiride, dexilant, curalin, krill oil, immuniti, breathe, estroven
Allergien
Metformin
Vorherige Impfungen
-

VAERS 1112465

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FN6200

mild
Staat
CA
Alter
63,0
Geschlecht
F
Eingang
18.03.2021
Impfdatum
21.02.2021
Beginn
21.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect route of product administration Injection site bruising Injection site erythema Injection site swelling

Symptomtext

The vaccine appears to have been delivered subcutaneously, not IM as prescribed. The individual was short, stood behind me, and I did not feel the needle enter the muscle as I had during my first injection. I assumed they were more skilled or I was more relaxed during the injection, so I didn't think anything of it. The next day, there was a small bruise at the injection site and a raised red area emanating from the injection site anteriorly approximately 1 inch over the anterior deltoid. The raised area could be palpated just under the skin and on top of the muscle and took nearly 2 weeks to resolve. This was very different than my first vaccine injection experience approx. 3 weeks prior, when I felt the needle enter the middle deltoid muscle, resulting in a round raised red area about the size of a quarter that felt deep in the muscle the next day, and which resolved in a few days. No other signs or symptoms noted. I called the Health Department, as well as Pfizer to advise them of the incident and to request advice. Both suggested filing a report but neither offered any advise other than to contact my MD, who also had no advice to offer. Questions: Given the temperature requirements of the Pfizer vaccine, and if it was not injected into the muscle, would a slower uptake impact my immunity? What is suggested to assess my current immunity status? Might a booster shot may be indicated? Any advice would be sincerely appreciated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-